Adverse events of nucleos(t)ide analogues for chronic hepatitis B: a systematic review

Nucleos(t)ide analogues (NAs) are the main drug category used in chronic hepatitis B (CHB) treatment. Despite the fact that NAs have a favourable safety profile, undesired adverse events (AEs) may occur during the treatment of CHB. Given the eminent number of patients currently receiving NAs, even a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Gastroenterol
Main Authors: de Fraga, Raquel Scherer, Van Vaisberg, Victor, Mendes, Luiz Cláudio Alfaia, Carrilho, Flair José, Ono, Suzane Kioko
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Singapore 2020
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7188775/
https://ncbi.nlm.nih.gov/pubmed/32185517
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00535-020-01680-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados